Beyond Pericardium: Expanding Tissue Sources for Heart Valve Replacement

Valvular heart disease remains a significant global health burden, particularly in regions with high rheumatic heart disease prevalence. Therefore, surgical experts are refining autologous heart valve constructs to minimize complications related to traditional mechanical or xenogeneic prostheses. While pericardial tissue is the current gold standard for intraoperative manufacturing, some patients lack sufficient usable tissue due to prior cardiac interventions. This study explores whether the peritoneum can serve as a suitable, biocompatible alternative for these complex cases.

Optimizing Intraoperative Tissue Treatment

Researchers recently optimized a specialized cross-linking method to enhance tissue properties during the surgical window. Furthermore, they tested this method extensively on both pericardial and peritoneal tissues to ensure clinical safety. The results showed that the treated tissues possessed high cytocompatibility, making them safe for implantation. Notably, the peritoneum demonstrated a significantly higher elastin content than its pericardial counterpart. This biochemical difference creates a looser structural organization, which ultimately alters its mechanical response under hemodynamic pressure.

Innovative Autologous Heart Valve Constructs

In addition to biochemical testing, the research team assessed the feasibility of manually shaping these tissues into valve leaflets. Both materials allowed for the creation of functional autologous heart valve constructs that performed well under acute hydrodynamic tests. Specifically, the peritoneal valves showed adequate opening and closing behavior under simulated physiological conditions. However, the study highlights that peritoneal tissue behaves differently from pericardium due to its unique microstructure. Consequently, surgeons must account for these mechanical variations during the design and shaping process.

Future Outlook for Peritoneal Scaffolds

While the initial findings are promising, several challenges remain before widespread clinical adoption. Moreover, future studies must evaluate how these constructs handle long-term cyclic loading and potential tissue remodeling in vivo. Nevertheless, identifying the peritoneum as a viable scaffold provides a vital backup for patients with depleted pericardial stores. This advancement could revolutionize intraoperative valve manufacturing by offering a versatile tissue source for complex re-do surgeries.

Frequently Asked Questions

Why is the peritoneum being considered for heart valves?

The peritoneum is considered because it is an autologous tissue source with similar embryologic origins to vascular tissue. It provides a viable alternative for patients who lack sufficient pericardium due to previous heart surgeries.

How does the peritoneum differ mechanically from the pericardium?

Peritoneal tissue has a higher elastin content and a looser structural organization compared to the pericardium. This results in distinct mechanical behaviors that require specific optimization during the valve-shaping process.

What is the benefit of using autologous tissue constructs?

Using the patient\'s own tissue reduces the risk of immune rejection and calcification often seen with foreign materials. It also offers the potential for the valve to remodel and integrate with the native cardiac environment.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Steitz M et al. Identification of Autologous Tissue Sources and Optimization of a Treatment Method for Intraoperative Manufacturing of Heart Valve Constructs. Artif Organs. 2026 Apr 26. doi: 10.1111/aor.70151. PMID: 42036733.

Fadali AM, Ramos MD, Topaz SR, Gott VL. The use of autogenous peritoneum for heart valve replacement. J Thorac Cardiovasc Surg. 1970 Aug;60(2):188-195. PMID: 5451062.

Ayyash et al. Mechanotransduction of autotransplants: remodeling potential of heart valves from autologous pericardial tissue. Frontiers in Cardiovascular Medicine. 2025;12:1152.